Opelconazole (PC945)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Opelconazole (PC945), covering 2026-01-15 to 2026-01-15. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of PC945 (Opelconazole) in Combination With Other Antifungal Therapy for the Treatment of Refractory Invasive Pulmonary Aspergillosis (OPERA-T Study) [Phase 3]